Akums Drugs Valuation
| AKUMS Stock | 500.45 5.25 1.04% |
At this time, the firm appears to be overvalued. Akums Drugs shows a prevailing Real Value of USD445.2 per share. The current price of the firm is USD500.45. Our model approximates the value of Akums Drugs from analyzing the firm fundamentals such as Shares Owned By Insiders of 82.61 %, current valuation of 134.21 B, and Profit Margin of 0.06 % as well as examining its technical indicators and probability of bankruptcy.
Price Book 18.5346 | Enterprise Value 134.2 B | Enterprise Value Ebitda 102.7568 | Price Sales 3.0942 | Trailing PE 10.4 K |
Overvalued
Today
Please note that Akums Drugs' price fluctuation is very steady at this time. Calculation of the real value of Akums Drugs is based on 3 months time horizon. Increasing Akums Drugs' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Akums Drugs is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Akums Stock. However, Akums Drugs' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 500.45 | Real 445.2 | Hype 501.81 | Naive 516.75 |
The intrinsic value of Akums Drugs' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Akums Drugs' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Akums Drugs and helps investors to forecast how Akums stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Akums Drugs more accurately as focusing exclusively on Akums Drugs' fundamentals will not take into account other important factors: Akums Drugs Total Value Analysis
Akums Drugs and is presently anticipated to have takeover price of 134.21 B with market capitalization of 130.91 B, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Akums Drugs fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
134.21 B | 130.91 B |
Akums Drugs Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Akums suggests not a very effective usage of assets in March.Akums Drugs Ownership Allocation
Akums Drugs holds a total of 157.39 Million outstanding shares. Akums Drugs and shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 82.61 percent of Akums Drugs outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.About Akums Drugs Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Akums Drugs and. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Akums Drugs based exclusively on its fundamental and basic technical indicators. By analyzing Akums Drugs's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Akums Drugs's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Akums Drugs. We calculate exposure to Akums Drugs's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Akums Drugs's related companies.Other Information on Investing in Akums Stock
Akums Drugs financial ratios help investors to determine whether Akums Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Akums with respect to the benefits of owning Akums Drugs security.